Loading...
Recombinant human gamma-interferon in primary hepatocellular carcinoma.
A phase II trial of recombinant human gamma-interferon in the treatment of unresectable primary hepatocellular carcinoma is reported. The trial was terminated prematurely after recruitment of only 7 patients because of unacceptable toxicity, predominantly renal. There was no evidence of response in...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
1985
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1289947/ https://ncbi.nlm.nih.gov/pubmed/2413205 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|